BENGALURU, India, July, 2026 — Merck, a leading science and technology company, today announced the appointment of Sakshi Yadav as Head of Process Solutions, India. Effective August 1, 2026, Sakshi will lead the Process Solutions business in India, with a focus on accelerating strategic growth, strengthening customer partnerships, and reinforcing Merck’s commitment to advancing the country’s rapidly evolving biopharmaceutical manufacturing ecosystem.
“Sakshi’s appointment reflects Merck’s commitment to nurturing internal talent and building a strong pipeline of future-ready leaders. Sakshi joined Merck in 2019 and has held leadership positions in commercial, managing director’s office and business excellence. Sakshi brings a strong track record of driving sustainable growth, leading business transformation, and building high-performing, collaborative teams,” said Tony Budianto Bee, Head of Process Solutions, Asia Pacific excluding China, Life Science business of Merck.
As Head of Process Solutions for India, Sakshi will spearhead strategic initiatives, and drive operational excellence, further elevating our customer experience in the Indian market.
As she takes on her new role, Sakshi Yadav said, “India’s biopharmaceutical sector is at an inflection point, driven by innovation, rapid capacity expansion, and a focus on quality and sustainability. I look forward to leading Merck’s Process Solutions business in India and working alongside our customers to accelerate innovation, strengthen manufacturing capabilities, and enable broader access to the next generation of life-saving therapies.”
With more than two decades of experience in the life sciences industry, Sakshi has consistently built high-performing teams while fostering a culture of innovation and customer centricity.
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck generated sales of € 21.1 billion in 65 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
